Zogenix Cash from Investing TTM:
-0.293M for Dec. 31, 2012Zogenix Historical Cash from Investing TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -0.293M |
| Sept. 30, 2012 | -0.446M |
| June 30, 2012 | -0.542M |
| March 31, 2012 | -0.609M |
| Dec. 31, 2011 | -0.617M |
| Sept. 30, 2011 | -1.784M |
| June 30, 2011 | -2.646M |
| March 31, 2011 | -2.68M |
| Dec. 31, 2010 | -3.442M |
About Cash From Investing (TTM)
ZGNX Cash from Investing TTM Benchmarks
| Companies | |
|---|---|
| Johnson & Johnson | -9.969B |
| GlaxoSmithKline | -4.923B |
| Tetraphase Pharmaceuticals |
ZGNX Cash from Investing TTM Rankings
| Overall |
84th percentile 1276 of 8005 |
| Sector |
68th percentile 216 of 686 in Healthcare |
| Industry |
67th percentile 18 of 55 in Drug Manufacturers - Major |
ZGNX Cash from Investing TTM Range, Past 5 Years
| Minimum | -3.442M | Dec 2010 |
| Maximum | -0.2930M | Dec 2012 |
| Average | -1.451M |
ZGNX News
Impax Labs (IPXL), Zogenix (ZGNX) Rise as FDA Won't Block Generic Opana (ENDP)
Street Insider May 10
Street Insider May 10